Oestrogen binding patterns 'could signal breast cancer relapse'

5 January 2012

The binding of the female hormone oestrogen to different parts of the genome in breast cancer patients could signal those who are more likely to relapse in the future.

Researchers at Cancer Research UK's Cambridge Research Institute have found that the female sex hormone attaches to a different part of DNA, which could have an effect on the methods of treatment conventionally used.

The scientists discovered that the protein FOXA1 redirects the oestrogen receptor (ER) and causes the irregular reattachment.

However, the findings published in the journal Nature point out that treatments used to block FOXA1 proteins could help patients who do not respond to usual cancer treatment drugs such as tamoxifen.

Cancer Research UK's Dr Jason Carroll, who led the study with Professor Carlos Caldas, said: "These findings suggest that ER binds to different regions of the genome DNA in breast cancer patients that respond to treatment, compared to those that relapse and whose cancer spreads."

The charity recently reported that the Experimental Cancer Medicine Centres  network, which runs UK clinical studies of the newest cancer treatments, was awarded £35 million in funding for research and trials over the next five years.

Posted by Jeanette Royston

Ross-Innes et al., "Differential oestrogen receptor binding is associated with clinical outcome in breast cancer (2012)", Nature, January 2012

 

Health News is provided by Adfero in collaboration with Spire Healthcare. Please note that all copy above is ©Adfero Ltd. and does not reflect views or opinions of Spire Healthcare unless explicitly stated. Additional comments on the page from individual Spire consultants do not necessarily reflect the views or opinions of other consultants or Spire Healthcare.

Find a treatment, test or scan available at:

or

Find a consultant

Use one or more of the options below to search for a consultant and link through to view their Spire profile.

or

Let us help you

fill out this form and we will get back to you:

Please select a hospital

We can call you

Please enter your details below and we will call you back.

What is the aim of your enquiry?

Please select a hospital

If we are unable to reach you by phone, please include your email address so that we can get in touch...

Categories

Cancer

© Spire Healthcare Group plc (2016)